Dr Azeem Latib, Director of Interventional Cardiology and Structural Heart Interventions
(Montefiore Health System New York), commented:
“I am enthused to note the post-procedure patient outcomes seen in US patients not only corroborated
with data reported from previous cohorts but exceeded them. The ability to use this device with such
excellent haemodynamic results, as well as ease of use, is incredible progress in the treatment of patients
with severe aortic stenosis.”
Ann: Anteris Completes DurAVR THV EFS Enrolment, page-3
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.20 |
Change
0.000(0.00%) |
Mkt cap ! $349.8M | |||
| Open | High | Low | Value | Volume |
| $18.20 | $18.20 | $18.20 | $8.281K | 455 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250 | $18.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.29 | 310 | 1 |
View Market Depth
| Last trade - 10.00am 27/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |